2013-09-13 11:30:57 - New Biotechnology research report from MarketLine is now available from Fast Market Research
Biotechnology in Belgium industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Belgium biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
* The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
* The Belgian biotechnology market had total revenues of $6.2bn in 2012, representing a compound annual growth rate (CAGR) of 7.9% between 2008 and 2012.
* While Belgium represents
less than 3.0% of the European population, it has approximately 140 biotech companies, which accounts for 7.0% of all European biotech firms, and employs around 10,000 people.
* The performance of the market is forecast to decelerate, with an anticipated CAGR of 6.6% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $8.5bn by the end of 2017.
Full Report Details at
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Belgium
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Belgium
Leading company profiles reveal details of key biotechnology market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Belgium biotechnology market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Belgium economy
Key Questions Answered
What was the size of the Belgium biotechnology market by value in 2012?
What will be the size of the Belgium biotechnology market in 2017?
What factors are affecting the strength of competition in the Belgium biotechnology market?
How has the market performed over the last five years?
What are the main segments that make up Belgium's biotechnology market?
Report Table of Contents:
TABLE OF CONTENTS
Market value forecast
Market value forecast
Five Forces Analysis
Threat of substitutes
Degree of rivalry
Related MarketLine research
LIST OF TABLES
Table 1: Belgium biotechnology market value: $ billion, 2008-12
Table 2: Belgium biotechnology market category segmentation: $ billion, 2012
Table 3: Belgium biotechnology market geography segmentation: $ billion, 2012
Table 4: Belgium biotechnology market value forecast: $ billion, 2012-17
Table 5: Novartis AG: key facts
Table 6: Novartis AG: key financials ($)
Table 7: Novartis AG: key financial ratios
Table 8: Sanofi: key facts
Table 9: Sanofi: key financials ($)
Table 10: Sanofi: key financials (EUR)
Table 11: Sanofi: key financial ratios
Table 12: ThromboGenics NV: key facts
Table 13: ThromboGenics NV: key financials ($)
Table 14: ThromboGenics NV: key financials (EUR)
Table 15: ThromboGenics NV: key financial ratios
Table 16: AstraZeneca PLC: key facts
Table 17: AstraZeneca PLC: key financials ($)
Table 18: AstraZeneca PLC: key financial ratios
Table 19: Belgium size of population (million), 2008-12
Table 20: Belgium gdp (constant 2000 prices, $ billion), 2008-12
Table 21: Belgium gdp (current prices, $ billion), 2008-12
Table 22: Belgium inflation, 2008-12
Table 23: Belgium consumer price index (absolute), 2008-12
Table 24: Belgium exchange rate, 2008-12
LIST OF FIGURES
Figure 1: Belgium biotechnology market value: $ billion, 2008-12
Figure 2: Belgium biotechnology market category segmentation: % share, by value, 2012
Figure 3: Belgium biotechnology market geography segmentation: % share, by value, 2012
Figure 4: Belgium biotechnology market value forecast: $ billion, 2012-17
Figure 5: Forces driving competition in the biotechnology market in Belgium, 2012
Figure 6: Drivers of buyer power in the biotechnology market in Belgium, 2012
Figure 7: Drivers of supplier power in the biotechnology market in Belgium, 2012
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology market in Belgium, 2012
Figure 9: Factors influencing the threat of substitutes in the biotechnology market in Belgium, 2012
Figure 10: Drivers of degree of rivalry in the biotechnology market in Belgium, 2012
Figure 11: Novartis AG: revenues & profitability
Figure 12: Novartis AG: assets & liabilities
Figure 13: Sanofi: revenues & profitability
Figure 14: Sanofi: assets & liabilities
Figure 15: ThromboGenics NV: assets & liabilities
Figure 16: AstraZeneca PLC: revenues & profitability
Figure 17: AstraZeneca PLC: assets & liabilities
MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.